We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTAI icon
3751
BioXcel Therapeutics
BTAI
$28.8M
$23K ﹤0.01%
51
-56
-52% -$30.5K
EFAV icon
3752
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.47B
$23K ﹤0.01%
301
+5
+2% +$377
FDMT icon
3753
4D Molecular Therapeutics
FDMT
$600M
$23K ﹤0.01%
970
+366
+61% +$11.2K
FRBA icon
3754
First Bank
FRBA
$458M
$23K ﹤0.01%
1,763
-110
-6% -$1.43K
GPK icon
3755
Graphic Packaging
GPK
$3.54B
$23K ﹤0.01%
1,270
-55,426
-98% -$1.01M
HSTM icon
3756
HealthStream
HSTM
$829M
$23K ﹤0.01%
818
-2,612
-76% -$65.7K
KE
3757
Kimball Electronics
KE
$607M
$23K ﹤0.01%
1,077
-735
-41% -$16.6K
KRRO icon
3758
Korro Bio
KRRO
$196M
$23K ﹤0.01%
46
+10
+28% +$4.88K
KVHI icon
3759
KVH Industries
KVHI
$151M
$23K ﹤0.01%
1,855
-279
-13% -$3.77K
LFVN icon
3760
LifeVantage
LFVN
$84M
$23K ﹤0.01%
3,046
+1,145
+60% +$9.35K
MOFG
3761
DELISTED
MidWestOne Financial Group
MOFG
$23K ﹤0.01%
792
-491
-38% -$15.1K
NDLS icon
3762
Noodles & Co
NDLS
$93M
$23K ﹤0.01%
234
-282
-55% -$26.2K
PAY icon
3763
Paymentus
PAY
$5.11B
$23K ﹤0.01%
+636
New +$19.9K
PKX icon
3764
POSCO
PKX
$17.3B
$23K ﹤0.01%
300
-1,438
-83% -$114K
PROV icon
3765
Provident Financial
PROV
$112M
$23K ﹤0.01%
1,355
-696
-34% -$11.7K
RDHL
3766
Redhill Biopharma
RDHL
$3.65M
$23K ﹤0.01%
3
+1
+50% +$6.9K
RRBI icon
3767
Red River Bancshares
RRBI
$674M
$23K ﹤0.01%
442
-145
-25% -$7.88K
SCHG icon
3768
Schwab US Large-Cap Growth ETF
SCHG
$62.7B
$23K ﹤0.01%
1,264
-6,488
-84% -$112K
THR
3769
DELISTED
Thermon Group Holdings
THR
$23K ﹤0.01%
1,366
-6,024
-82% -$112K
TIGO icon
3770
Millicom
TIGO
$15.9B
$23K ﹤0.01%
583
-428
-42% -$17.8K
TLS icon
3771
Telos
TLS
$321M
$23K ﹤0.01%
666
-180
-21% -$6.06K
TRTX
3772
TPG RE Finance Trust
TRTX
$614M
$23K ﹤0.01%
1,696
-9,501
-85% -$122K
WRAP icon
3773
Wrap Technologies
WRAP
$104M
$23K ﹤0.01%
2,868
-991
-26% -$6.79K
ASXC
3774
DELISTED
Asensus Surgical, Inc.
ASXC
$23K ﹤0.01%
+7,349
New +$18.4K
CONN
3775
DELISTED
Conn's Inc.
CONN
$23K ﹤0.01%
877
-441
-33% -$10.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.